Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.

[1]  Howard Y. Chang,et al.  Clonal replacement of tumor-specific T cells following PD-1 blockade , 2019, Nature Medicine.

[2]  S. Shaffer,et al.  HLA-DO Modulates the Diversity of the MHC-II Self-peptidome. , 2019, Molecular & cellular proteomics : MCP.

[3]  Michele A. Busby,et al.  Supplementary Materials for Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification , 2018 .

[4]  Alessandro Sette,et al.  The Immune Epitope Database (IEDB): 2018 update , 2018, Nucleic Acids Res..

[5]  V. Yotova,et al.  Gene activation precedes DNA demethylation in response to infection in human dendritic cells , 2018, Proceedings of the National Academy of Sciences.

[6]  M. Nielsen,et al.  Footprints of antigen processing boost MHC class II natural ligand predictions , 2018, Genome Medicine.

[7]  Anthony Liew,et al.  Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq , 2018, PloS one.

[8]  Monika S. Kowalczyk,et al.  A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade , 2018, Cell.

[9]  H. Rammensee,et al.  Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation. , 2018, Cancer research.

[10]  Sandeep Kumar Dhanda,et al.  Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands , 2018, Front. Immunol..

[11]  P. Carmeliet,et al.  Phenotype molding of stromal cells in the lung tumor microenvironment , 2018, Nature Medicine.

[12]  J. Gartner,et al.  Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer , 2018, Nature Medicine.

[13]  D. Neri,et al.  Membranal and Blood‐Soluble HLA Class II Peptidome Analyses Using Data‐Dependent and Independent Acquisition , 2018, Proteomics.

[14]  J. Gartner,et al.  T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers , 2018, Clinical Cancer Research.

[15]  C. Freund,et al.  Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility , 2018, Front. Immunol..

[16]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[17]  N. Bhardwaj,et al.  Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment. , 2018, Trends in cancer.

[18]  Markus Müller,et al.  High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome* , 2017, Molecular & Cellular Proteomics.

[19]  Angela E. Leek,et al.  Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution , 2017, Cell.

[20]  Oliver Kohlbacher,et al.  The immunopeptidomic landscape of ovarian carcinomas , 2017, Proceedings of the National Academy of Sciences.

[21]  Shawn M. Gillespie,et al.  Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer , 2017, Cell.

[22]  M. Nielsen,et al.  Computational Tools for the Identification and Interpretation of Sequence Motifs in Immunopeptidomes , 2017, bioRxiv.

[23]  Nir Hacohen,et al.  Resistance to checkpoint blockade therapy through inactivation of antigen presentation , 2017, Nature Communications.

[24]  J. Lunceford,et al.  IFN-&ggr;–related mRNA profile predicts clinical response to PD-1 blockade , 2017, The Journal of clinical investigation.

[25]  J. Utikal,et al.  Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer , 2017, Nature.

[26]  Charles H. Yoon,et al.  An immunogenic personal neoantigen vaccine for patients with melanoma , 2017, Nature.

[27]  Andreas Handel,et al.  Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells , 2017, Nature.

[28]  Morten Nielsen,et al.  GibbsCluster: unsupervised clustering and alignment of peptide sequences , 2017, Nucleic Acids Res..

[29]  L. J. K. Wee,et al.  Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors , 2017, Nature Genetics.

[30]  Jennifer G. Abelin,et al.  Mass Spectrometry Profiling of HLA‐Associated Peptidomes in Mono‐allelic Cells Enables More Accurate Epitope Prediction , 2017, Immunity.

[31]  Ash A. Alizadeh,et al.  Antigen Presentation Profiling Reveals Recognition of Lymphoma Immunoglobulin Neoantigens , 2017, Nature.

[32]  Ruth L. Seal,et al.  Genenames.org: the HGNC and VGNC resources in 2017 , 2016, Nucleic Acids Res..

[33]  W. Kwok,et al.  Tetramer-Guided Epitope Mapping: A Rapid Approach to Identify HLA-Restricted T-Cell Epitopes from Composite Allergens. , 2017, Methods in molecular biology.

[34]  M. Mann,et al.  Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry , 2016, Nature Communications.

[35]  K. Rock,et al.  Present Yourself! By MHC Class I and MHC Class II Molecules. , 2016, Trends in immunology.

[36]  S. Gygi,et al.  Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. , 2016, Cell systems.

[37]  David Gfeller,et al.  Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide–HLA Interactions , 2016, The Journal of Immunology.

[38]  Anders Eklund,et al.  Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples * , 2016, Molecular & Cellular Proteomics.

[39]  B. Schröder.  The multifaceted roles of the invariant chain CD74--More than just a chaperone. , 2016, Biochimica et biophysica acta.

[40]  Charles H. Yoon,et al.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.

[41]  Yu Shyr,et al.  Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy , 2016, Nature Communications.

[42]  Valerio Zolla,et al.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity* , 2016, The Journal of Biological Chemistry.

[43]  Shabaz Mohammed,et al.  Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity* , 2016, Molecular & Cellular Proteomics.

[44]  Ellen T. Gelfand,et al.  A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project , 2015, Biopreservation and biobanking.

[45]  Morten Nielsen,et al.  Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification , 2015, Immunogenetics.

[46]  L. Stern,et al.  Evaluating the Role of HLA-DM in MHC Class II–Peptide Association Reactions , 2015, The Journal of Immunology.

[47]  Steven J. M. Jones,et al.  Genomic Classification of Cutaneous Melanoma , 2015, Cell.

[48]  S. Carr,et al.  Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS , 2015, Nature.

[49]  L. Emens,et al.  The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies , 2015, Cancer Immunology Research.

[50]  J. Castle,et al.  Mutant MHC class II epitopes drive therapeutic immune responses to cancer , 2015, Nature.

[51]  Sergey Ioffe,et al.  Batch Normalization: Accelerating Deep Network Training by Reducing Internal Covariate Shift , 2015, ICML.

[52]  Jian Sun,et al.  Delving Deep into Rectifiers: Surpassing Human-Level Performance on ImageNet Classification , 2015, 2015 IEEE International Conference on Computer Vision (ICCV).

[53]  Jimmy Ba,et al.  Adam: A Method for Stochastic Optimization , 2014, ICLR.

[54]  James Robinson,et al.  The IPD and IMGT/HLA database: allele variant databases , 2014, Nucleic Acids Res..

[55]  Gert Vriend,et al.  A series of PDB related databases for everyday needs , 2010, Nucleic Acids Res..

[56]  Morten Nielsen,et al.  Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires , 2014, Immunogenetics.

[57]  A. Pliss,et al.  Transformations of the macromolecular landscape at mitochondria during DNA-damage-induced apoptotic cell death , 2014, Cell Death and Disease.

[58]  Pierre Baldi,et al.  SSpro/ACCpro 5: almost perfect prediction of protein secondary structure and relative solvent accessibility using profiles, machine learning and structural similarity , 2014, Bioinform..

[59]  S. Rosenberg,et al.  Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer , 2014, Science.

[60]  Albert J R Heck,et al.  Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD) , 2014, Proceedings of the National Academy of Sciences.

[61]  S. Carr,et al.  Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells , 2014, Science.

[62]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[63]  Nitish Srivastava,et al.  Dropout: a simple way to prevent neural networks from overfitting , 2014, J. Mach. Learn. Res..

[64]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[65]  O. Lund,et al.  NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ , 2013, Immunogenetics.

[66]  Drew A. Torigian,et al.  A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside , 2013, Clinical Cancer Research.

[67]  Clemencia Pinilla,et al.  Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture , 2013, Current protocols in immunology.

[68]  Lukasz A. Kurgan,et al.  D2P2: database of disordered protein predictions , 2012, Nucleic Acids Res..

[69]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[70]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[71]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[72]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[73]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[74]  Norman E. Davey,et al.  Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins , 2012, Cell.

[75]  S. Rosenberg,et al.  Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes , 2012, Journal of immunotherapy.

[76]  Ilka Hoof,et al.  Proteome Sampling by the HLA Class I Antigen Processing Pathway , 2012, PLoS Comput. Biol..

[77]  A. McKenna,et al.  Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.

[78]  Jacob D. Jaffe,et al.  Methods for Quantification of in vivo Changes in Protein Ubiquitination following Proteasome and Deubiquitinase Inhibition* , 2012, Molecular & Cellular Proteomics.

[79]  D. Hafler,et al.  Class II MHC Self-Antigen Presentation in Human B and T Lymphocytes , 2012, PloS one.

[80]  Jörn Dengjel,et al.  Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. , 2011, Journal of proteome research.

[81]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[82]  Matthew R. Clutter,et al.  Fluorescent Cell Barcoding for Multiplex Flow Cytometry , 2011, Current protocols in cytometry.

[83]  Tim A. H. te Beek,et al.  A series of PDB related databases for everyday needs , 2010, Nucleic Acids Res..

[84]  M. van Lith,et al.  HLA-DP, HLA-DQ, and HLA-DR Have Different Requirements for Invariant Chain and HLA-DM* , 2010, The Journal of Biological Chemistry.

[85]  Geoffrey E. Hinton,et al.  Rectified Linear Units Improve Restricted Boltzmann Machines , 2010, ICML.

[86]  J. Cubillos-Ruiz,et al.  CD4+ T Cells Elicit Host Immune Responses to MHC Class II− Ovarian Cancer through CCL5 Secretion and CD40-Mediated Licensing of Dendritic Cells , 2010, The Journal of Immunology.

[87]  R. Blasberg,et al.  Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts , 2010, The Journal of experimental medicine.

[88]  S. H. van der Burg,et al.  Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. , 2009, The New England journal of medicine.

[89]  Clemencia Pinilla,et al.  Derivation of an amino acid similarity matrix for peptide:MHC binding and its application as a Bayesian prior , 2009, BMC Bioinformatics.

[90]  Morten Nielsen,et al.  NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction , 2009, BMC Bioinformatics.

[91]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[92]  Søren Buus,et al.  Functional recombinant MHC class II molecules and high-throughput peptide-binding assays , 2009, Immunome research.

[93]  N Leigh Anderson,et al.  High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. , 2008, Clinical chemistry.

[94]  M. Mann,et al.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips , 2007, Nature Protocols.

[95]  Andrew W. Liu,et al.  Multiplex mapping of CD4 T cell epitopes using class II tetramers. , 2006, Clinical immunology.

[96]  Pierre Baldi,et al.  SCRATCH: a protein structure and structural feature prediction server , 2005, Nucleic Acids Res..

[97]  T. Mohanakumar,et al.  In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers. , 2004, Human immunology.

[98]  E. Sercarz,et al.  MHC-guided processing: binding of large antigen fragments , 2003, Nature Reviews Immunology.

[99]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[100]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[101]  John Sidney,et al.  Measurement of MHC/Peptide Interactions by Gel Filtration , 1999, Current protocols in immunology.

[102]  C. Melief,et al.  Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors , 1998, The Journal of experimental medicine.

[103]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[104]  S. Henikoff,et al.  Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[105]  P. Cresswell,et al.  Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain , 1991, Nature.

[106]  Lawrence D. Jackel,et al.  Backpropagation Applied to Handwritten Zip Code Recognition , 1989, Neural Computation.